1. |
Devinsky O, Vezzani A, O'Brien TJ, et al. Epilepsy. Nat Rev Dis Primers, 2018, 4: 18024.
|
2. |
Vezzani A, Balosso S, Ravizza T. Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol, 2019, 15(8): 459-472.
|
3. |
Wu C, Zhang G, Chen L, et al. The role of nlrp3 and il-1beta in refractory epilepsy brain injury. Front Neurol, 2019, 10: 1418.
|
4. |
Alyu F, Dikmen M. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr, 2017, 29(1): 1-16.
|
5. |
Mohseni-Moghaddam P, Roghani M, Khaleghzadeh-Ahangar H, et al. A literature overview on epilepsy and inflammasome activation. Brain Res Bull, 2021, 172: 229-235.
|
6. |
Mangan MSJ, Olhava EJ, Roush WR, et al. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat Rev Drug Discov., 2018, 17(8): 588-606.
|
7. |
Grebe A, Hoss F, Latz E. NLRP3 Inflammasome and the IL-1 pathway in atherosclerosis. Circ Res, 2018, 122(12): 1722-1740.
|
8. |
Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol, 2009, 183(2): 787-791.
|
9. |
Zeng QZ, Yang F, Li CG, et al. Paclitaxel enhances the innate immunity by promoting nlrp3 inflammasome activation in macrophages. Front Immunol, 2019, 10: 72.
|
10. |
Cristina de BTE, Leandro MVE, Boni RDB, et al. NLRP3 and NLRP1 inflammasomes are up-regulated in patients with mesial temporal lobe epilepsy and may contribute to overexpression of caspase-1 and IL-beta in sclerotic hippocampi. Brain Res, 2021, 1752: 147230.
|
11. |
Shen K, Mao Q, Yin X, et al. NLRP3 Inflammasome activation leads to epileptic neuronal apoptosis. Curr Neurovasc Res, 2018, 15(4): 276-281.
|
12. |
Zhang H, Yu S, Xia L, et al. NLRP3 inflammasome activation enhances ADK expression to accelerate epilepsy in mice. Neurochem Res, 2022, 47(3): 713-722.
|
13. |
Wang Z, Zhou L, An D, et al. TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice. Cell Death Dis, 2019, 10(6): 386.
|
14. |
Malko P, Syed Mortadza SA, McWilliam J, et al. TRPM2 channel in microglia as a new player in neuroinflammation associated with a spectrum of central nervous system pathologies. Front Pharmacol, 2019, 10: 239.
|
15. |
Hu H, Zhu T, Gong L, et al. Transient receptor potential melastatin 2 contributes to neuroinflammation and negatively regulates cognitive outcomes in a pilocarpine-induced mouse model of epilepsy. Int Immunopharmacol, 2020, 87: 106824.
|
16. |
Yue J, He J, Wei Y, et al. Decreased expression of Rev-Erbalpha in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbalpha have anti-inflammatory and neuroprotective effects in the pilocarpine model. J Neuroinflammation, 2020, 17(1): 43.
|
17. |
Jiang Q, Tang G, Zhong XM, et al. Role of Stat3 in NLRP3/caspase-1-mediated hippocampal neuronal pyroptosis in epileptic mice. Synapse, 2021, 75(12): e22221.
|
18. |
Yue J, Wei YJ, Yang XL, et al. NLRP3 inflammasome and endoplasmic reticulum stress in the epileptogenic zone in temporal lobe epilepsy: molecular insights into their interdependence. Neuropathol Appl Neurobiol, 2020, 46(7): 770-785.
|
19. |
Xiang T, Luo X, Ye L, et al. Klotho alleviates NLRP3 inflammasome-mediated neuroinflammation in a temporal lobe epilepsy rat model by activating the Nrf2 signaling pathway. Epilepsy Behav, 2022, 128: 108509.
|
20. |
Wang L, Ding J, Zhu C, et al. Semaglutide attenuates seizure severity and ameliorates cognitive dysfunction by blocking the NLR family pyrin domain containing 3 inflammasome in pentylenetetrazolekindled mice. Int J Mol Med, 2021, 48(6): 219.
|
21. |
Sakthivel KM, Guruvayoorappan C. Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-kappaB signal transduction pathways in rats with ulcerative colitis. Int Immunopharmacol, 2013, 17(3): 907-916.
|
22. |
Rong S, Wan D, Fan Y, et al. Amentoflavone Affects Epileptogenesis and Exerts Neuroprotective Effects by Inhibiting NLRP3 Inflammasome. Front Pharmacol, 2019, 10: 856.
|
23. |
Sun Y, Ma J, Li D, et al. Interleukin-10 inhibits interleukin-1beta production and inflammasome activation of microglia in epileptic seizures. J Neuroinflammation, 2019, 16(1): 66.
|
24. |
Liu R, Wu S, Guo C, et al. Ibuprofen exerts antiepileptic and neuroprotective effects in the rat model of pentylenetetrazol-induced epilepsy via the cox-2/nlrp3/il-18 pathway. Neurochem Res, 2020, 45(10): 2516-2526.
|
25. |
Xia S, Yang P, Li F, et al. Chaihu-Longgu-Muli Decoction exerts an antiepileptic effect in rats by improving pyroptosis in hippocampal neurons. J Ethnopharmacol, 2021, 270: 113794.
|
26. |
Li X, Lin J, Hua Y, et al. Agmatine alleviates epileptic seizures and hippocampal neuronal damage by inhibiting gasdermin d-mediated pyroptosis. Front Pharmacol, 2021, 12: 627557.
|
27. |
He Q, Jiang L, Man S, et al. Curcumin reduces neuronal loss and inhibits the nlrp3 inflammasome activation in an epileptic rat model. Curr Neurovasc Res, 2018, 15(3): 186-192.
|
28. |
Dai J, Jiang C, Chen H, et al. Rapamycin attenuates high glucose-induced inflammation through modulation of mtor/nf-kappab pathways in macrophages. Front Pharmacol, 2019, 10: 1292.
|
29. |
Aghaie F, Moradifar F, Hosseini A. Rapamycin attenuates depression and anxiety-like behaviors through modulation of the NLRP3 pathway in pentylenetetrazole-kindled male Wistar rats. Fundam Clin Pharmacol, 2021, 35(6): 1045-1054.
|
30. |
Wang ZF, Wang J, Zhang HY, et al. Huperzine A exhibits anti-inflammatory and neuroprotective effects in a rat model of transient focal cerebral ischemia. J Neurochem, 2008, 106(4): 1594-1603.
|
31. |
Mohseni-Moghaddam P, Sadr SS, Roghani M, et al. Huperzine A ameliorates cognitive dysfunction and neuroinflammation in kainic acid-induced epileptic rats by antioxidant activity and NLRP3/caspase-1 pathway inhibition. Clin Exp Pharmacol Physiol, 2019, 46(4): 360-372.
|
32. |
Shen K, Jiang W, Zhang C, et al. Molecular mechanism of a specific NLRP3 inhibitor to alleviate seizure severity induced by pentylenetetrazole. Curr Mol Pharmacol, 2021, 14(4): 579-586.
|
33. |
Kursun O, Yemisci M, van den Maagdenberg A, et al. Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain, 2021, 22(1): 55.
|
34. |
DeSena AD, Do T, Schulert GS. Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade. J Neuroinflammation, 2018, 15(1): 38.
|